Science, public policy and engagement: Debates on stem cell research in Brazil by unknown
17         Genomics, Society and Policy 
             2010/11, Vol.6, No.3 pp.15-31 
 
 
_____________    
 
Genomics, Society and Policy, Vol.6, No.3 (2010/11) ISSN: 1746-5354 
15
Science, public policy and engagement: Debates on stem cell research 




This paper analyses the main narratives, rhetorical resources and themes deployed 
during public contemporary debates on stem cell research (SCR) and cellular therapy 
in Brazil, an emergent global player. It examines the discursive rhetoric used to 
discuss adult and embryonic stem cell research and analyses the processes and main 
themes involved in the approval of the 2005 Biosecurity Law at the National Congress 
and, more specifically, during the 2007 public hearing at the Federal Supreme Court. 
Relying on previous academic work and supported by the analysis of public 
audiences´ transcriptions, key journal reports and 15 semi-structured face-to-face 
interviews, the paper focuses mainly on the common topics in the scientists´ 
narratives to map the characteristics of the Brazilian debates and establish the main 
convergences and divergences between the positions taken by opposing lobbies. 
These are illustrated by selected statements on recurrent themes and assumptions. 
There are three main areas of focus: forms of scientific, technical and moral 
construction of discourse and regulation; strategies towards civil society´s 
engagement and participation; and the country´s contributions to global genetics and 
health biotechnology. The paper argues that the specificities of the narratives 
deployed by the different social actors are a product not solely of sociocultural and 
religious backgrounds and practices, but also of local SRC development and social 
awareness, of the exercise of citizens´ rights, and of prevalent cultural trends in the 
local relations between science, medicine and society.  
Introduction 
Stem cell research (SCR) has increasingly become a global activity,2 in which 
initiatives from the industrialised and emerging economies promise important socio-
economic contributions, mainly through the design of new therapies for non-
infectious disease that has increased among ageing populations, also within the 
developing world.3 The use of embryonic stem cell lines as an innovation trajectory in 
research and isolated clinical trials, has given rise to international controversies 
relating to embryo use and disposal.4 These debates are also relevant for: the 
sustainability of high-risk experimental research in developing countries and for their 
technological choices, as well as, for the information on health-care the local ‘publics’ 
have access to and which they need in order to be able to participate as informed 
citizens in policy-making. Some of the technologies being researched by 
industrialised countries are being tested in emerging economies under dubious 
conditions.5 Future technological and regulatory regimes will articulate and influence 
each other.6 
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This paper examines the discursive rhetoric used during public debates on adult and 
embryonic stem cell research in Brazil and analyses the main themes and contents 
involved in the approval of the 2005 Biosecurity Law (Lei nº 11.105) at the National 
Congress and, more specifically, during the 2007 public hearing (ADIn 3510) at the 
Federal Supreme Court. The analysis focuses mainly on the common themes found in 
the scientists´ narratives7 to map the characteristics of the Brazilian debates and to 
establish the main convergences and divergences between the positions taken by 
opposing lobbies and the discourses each of them developed to engage public opinion 
(illustrated by selected statements on recurrent themes and assumptions). The paper 
argues that the specificities of the narratives deployed by the different social actors are 
a product not solely of sociocultural and religious backgrounds and practices, but also 
of local SRC development and social awareness, of the exercise of citizens´ rights, 
and of prevalent cultural trends in the local relations between science, medicine and 
society.  
Stages in the approval of the Brazilian 2005 Biosecurity Law 
In Brazil, a very long process of negotiation and public debate was required to change 
the 1995 Biosecurity Law (Lei nº 8.974) and approve its replacement (Lei nº 11.105). 
The legislative process included the following events: the approval of the first law on 
biosecurity (the 1995 law), the creation of a National Technical Commission on 
Biosecurity8 and challenges against its decisions on genetically modified organisms 
(GMOs); the 2003 law reform project; the initial approval of the new law in 2005; a 
federal legal case declaring its unconstitutionality (ADIn 3510); and its final approval 
in 2008.  
 
There were four distinct phases to this approval process, based on different social 
appraisals on biosecurity and on changing relations between science, medicine and 
society.9 Between 1997 and 2003, under increasing social pressure for regulation, the 
government sought approval of a law governing transgenic crops and foods. A 
vacuum of regulatory frameworks had facilitated agribusiness firms´ illegal 
commercialisation of several types of GMOs, mainly soya, cotton and maize. Local 
stem cell research had begun around 1999, promising many useful results for different 
medical fields. At that time, health innovation was developing within a generally 
positive context, due to the creation of the national public health system (Sistema 
Único de Saúde - SUS) in 1990, based upon the principle of healthcare for all free at 
the point of service. A basic trust relationship had been established between science, 
medicine and society, in spite of certain specific health controversies.10 
 
In 2003, the biosecurity law reform project was drafted. At the time, there was no 
specific federal law- and, indeed, to date there is still no specific law11 – to regulate 
the use of human embryos in research or assisted reproduction, although assisted 
reproduction has been expanding steadily since the early 1980s. This reform project 
was seen as an opportunity to negotiate the conditions for the approval of transgenic 
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During initial negotiations, the legal ban on ESCR, based on Article 6 of the 1995 
Biosecurity Law, banning the production, banking and manipulation of human 
embryos, was upheld. However, the ban was lifted when the 2003 law reform project 
was sent to the Deputy Chamber of Congress. Those opposing the ban, a majority in 
number and highly politically influential, reacted strongly. Within the Deputy 
Chamber of Congress opponents, grouped into two well-organised blocs, namely the 
Catholics (Bancada Católica) and the evangelicals (Frente Parlamentar Evangélico – 
FPE) - both aligned with anti-abortion groups - made an agreement to modify the 
latest draft of the bill, basing their decision on their religious convictions.13  
  
Between 2004 and 2005 those in favour of ESCR became better organised. Their 
lobby was composed mainly of scientists, patient organisations, individual severely ill 
patients and some (publicly prominent) disabled patients and their relatives, the latter 
grouped in the main Brazilian patient organisation: MOVITAE (Movimento em Prol 
da Vida).14 The scientific community in favour of ESCR and the other active 
organisations- including a highly visible group of local patients who could eventually 
benefit from SCR- formed an alliance with the lobby favourable to the cultivation of 
GMOs in Brazil, with whom they shared a similar strategy for the approval of 
regulation relevant to both topics.15  
 
Scientists from this lobby were invited to the 2004 public hearing at the Senate 
Chamber of Congress (one of the two Chambers in Congress, the other being the 
Deputies´ Chamber). They pursued a pragmatic strategy, presenting detailed research 
reports and making repeated references to ‘the opportunity for a humanitarian use’ of 
surplus and unviable frozen embryos in research. These were estimated at between 
20-30,000, which later proved to be a major overestimate. Scientists construed the 
disposal of frozen embryos as an inevitable daily and pre-existing by-product of the 
work of the fertility clinics, and defended ESCR as important to maintain and improve 
Brazil´s position in the biotechnology race and as a way of reducing public health 
expenditure in the future. Conceptual and ethical debates on embryo status were 
avoided, as well as all reference to ethically controversial techniques, such as 
therapeutic cloning.  
 
Some representatives at the Senate supported the scientists´ arguments and expressed 
their faith in the capacity of the scientists to obtain future benefits, such as those 
promised by cellular therapies.16 They considered scientific narratives to be neutral 
and attributed unique authority to them, vis-à-vis other forms of knowledge, as had 
been the case during previous discussions on GMOs.  
  
The 2004 Senate debate changed the balance of forces in Congress. During the last 
vote on the law in the Chamber of Deputies on 2 March 2005, many of the Christian 
deputies, especially the evangelicals, were already favourable towards the 
liberalisation of ESCR and the law was finally approved with 366 votes in favour and 
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‘Unconstitutionality’: The Brazilian 2007 Federal Supreme Court hearing  
On 16 May 2005, soon after the approval of the new law, the Brazilian attorney-
general Claudio Fonteles, a self-declared Catholic, filed a lawsuit (ADIn 3510) in the 
Federal Supreme Court (STF) declaring the law unconstitutional mainly because of its 
Article 5, which established the conditions under which ESCR was allowed to be 
carried out. These were apparently considered too liberal by the anti-ESCR lobby, 
whose central assumption, that human life begins at conception, for them a moral and 
religious conviction, was shared by the attorney-general.  
 
Article 5 of the approved law authorised the derivation of ESC from surplus embryos 
from in vitro fertilisation, if frozen for three or more years at the date of publication of 
the law; in-vitro embryos not yet frozen at that date could be used for research only 
after a three-year freezing period. The law also established the need for parental 
written informed consent (Art.5º, §1º) and for research institutes and health services 
working with ESC to submit their projects for approval to the relevant research ethics 
boards (Art.5º, §2º).17  
 
M. Fonteles presented an ethical/legal statement: that life begins at fertilisation, and 
then asked the Supreme Court to answer the question: When does life begin? The 
lawsuit´s argument, based upon the assumption mentioned, was that to accept research 
experimentation with human embryos was to hamper with the constitutional right to 
life. Between 2005 and 2007, research in the area continued intermittently with little 
public financial support and within a highly uncertain context. 
Format and Implementation 
The presiding justice, Carlos Ayres Britto, a practising Catholic, decided to hold a 
public hearing on 24 April 2007, the first in the STF’s history,18 in order to: “listen to 
presentations from people with experience and authority”.19 Explicitly, the hearing 
was intended to address the STF´s doubts, widen its technical knowledge and increase 
civil society´s participation in a socially relevant topic. Implicitly, the hearing was 
intended to increase the legitimacy of the STF´s decisions.20 
 
Twenty-two specialists were selected to present 20-minute individual research reports. 
These scientists were equally divided into two well-characterised opinion blocs: one 
against and one favourable to the lawsuit. A debate strategy was followed that 
conflated those against and in favour of the lawsuit with those against and in favour of 
ESCR. This arrangement was effectively a political strategy, as there could be only 
two sets of ‘valid’ opinions expressed among those scientists engaged in this specific 
debate on SCR in Brazil.  
 
Each bloc was assigned a little over two hours for presentations.21 There was no room 
for debate after each presentation or after each bloc’s contributions; the discussion of 
ideas, views and positions was explicitly dissuaded, as part of the rules of proceedings 
of the STF on public hearings. The participants were not free to raise questions; they 
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were there to answer the questions posed by the public attorney in the lawsuit and to 
inform the justices about facts and ethical/moral positions related to these questions.  
 
However, some justices characterised the hearing as:  
 
… a House for the People, th e same as Congress. A p lace where 
different social desires and political, ethical and religious pluralism 
finds a place in the debates ... Public  Hearings ... turn this Court into 
a democratic space. An open space for reflection and legal and moral 
argumentation with broad repercus sions upon ‘the collective’ and 
within democratic institutions (Justice Gilmar Mendes, a liberal 
lawyer and a Catholic by background)22 
  
... such a vivid and rich discussion … a m echanism of participatory 
or direct democracy ... Metaphoric ally, democracy involves giving a 
voice to all, m oving those who are us ually seated into the stage of 
collective decision-making (Justice Carlos Ayres Britto, a lawyer 
and poet, president of the public hearing and a practising 
Catholic).23 
 
The format of the hearing hampered the very practice that defines public debate, and 
was shaped in ways distant from “an example of democracy” 24; notwithstanding its 
value as a deliberative, informational and educational tool. The “stage of collective 
decision-making” 25 was occupied by the justices, with the support of a new epistemic 
scientific group.26 The strategy adopted was not necessarily the best one to obtain a 
democratically negotiated consensus for collective decision-making.  
  
Civil society´s actual engagement preceded the public hearing. NGO representatives 
and patients made trips to Brasilia, camped and convened meetings in front of the 
Supreme Court building, published reports in key national newspapers and on the web 
sites of participating organisations, and were interviewed on TV.  
 
Social actors’ initiatives tend to reflect the different civic epistemologies of the 
culture where the debate takes place.27 In the Brazilian case, they expressed 
contradictory and ambivalent social and moral/ethical beliefs within a culture 
undergoing a transition towards a more inclusive democracy. 
Definitions of human life and of science 
Ontological perspectives on the beginnings of human life and on the status of the 
embryo, perspectives that had been relatively silenced by ESCR supporters towards 
the end of the 2005 law approval process, were brought to the forefront at the public 
hearing. The two central questions asked by the justices were about the definition of 
unviable research embryos and about the ideal freezing period for embryos. 
 
The different meanings of human ‘life’ were obscured in the specialists’ 
presentations. Polarities between ‘good’ and ‘bad’ science and ‘science’ and ‘non-
science’ were used to mask those meanings, and also to create new boundaries for the 
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ESCR field. For example, when the importance of the three-year freezing period for 
research embryos was discussed, frontier-lines were drawn in each camp using 
opposite framings: the rights of the parents versus the rights of the embryo. ESCR 
supporters argued in terms of the ideal time for the parents to make an informed and 
definite decision on embryo donation. By contrast, their opponents argued that 
establishing a fixed period was intended to avoid the cloning of research embryos, as 
well as, embryo commerce and research fraud. 
 
ESCR opponents also expressed a perspective of nature as ‘untouched’ by culture, 
contrary to contemporary views on the mutual co-construction between nature and 
culture and of scientific facts.28 
  
When working from within nature´s approach is abandoned, all other 
definitions become arbitrary and there is a lack o f any framework to 
take any decision (Lenize Aparecida Martins Garcia, a biologist and 
professor and a practising Catholic).29 
 
This camp also tried to discredit their adversaries’ position on the decrease in frozen 
embryos’ viability for human reproduction over time, through repeated reference to 
successful reports on Brazilian children born as a result of in-vitro fertilisation using 
embryos frozen for periods between six and 12 years30 31. ESCR opponents also 
argued that the division between viable and unviable embryos led to an inappropriate 
classification into two types of people: normal and inadequate.  
 
Meanwhile, ESCR supporters characterised life as relational, gradual and in evolution, 
severing all its connections with embryo life. They also supported research on 
embryos selected through an ‘objective’ embryo-grading at the in-vitro fertilisation 
clinics32 33.  
 
Each group was suspicious of the data, evidence and scientific methods of the 
opposing bloc. ESCR opponents grounded their concerns about embryo research in 
what they described as, the “unanimous definitions within biology’s respectable 
literature” about the beginnings of human life34. Among the defenders, perspectives 
on human life and its hierarchies were contradictorily expressed: the embryo became 
‘a subject of its own decisions’:  
 
There is n o life in the frozen  embryo if there is no hum an 
intervention ... W e are defending that in the sam e way as an 
individual with cerebr al death can donate orga ns, a frozen em bryo 
could donate its cells  (Mayana Zatz, a Jewish geneticist by back 
ground and embryonic SC scientist).35  
 
Two striking features characterise the debate on this issue in Brazil. First, the 
differentiation between pre-embryos and embryos, based upon the shaping of the 
initial neurological system at around day 14 of embryo development, is used 
internationally to justify ESCR with cells collected at the ‘pre-embryo’ stage. But this 
distinction was absent from the discursive strategies deployed. Second, an 
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internationally prevalent paradigm shift in conventional perspectives about the initial 
unit of life had only minor relevance in the Brazilian context. This shift corresponds 
to that between a social perspective that considers embryos as the initial unit of 
human life, and that which assigns this place to the stem cell.36(In Brazil, this 
perspective still generates strong public opposition). Brazilian narratives focused upon 
drawing a boundary between viable in-vitro surplus embryos as potential initial units 
of life, and embryos unviable for assisted reproduction, reflecting dominant Christian 
religious and moral beliefs.37 
The shaping of a new epistemic scientific community 
SC scientists working with adult cells formed part of both blocs, but expressed 
opposite views. Those opposed to ESCR framed their arguments in relation to the lack 
of international therapeutic applications of embryo research, and/or to its risks, and 
emphasised the potential of adult SCs to substitute for embryonic SCs. Only one 
scientist in this group mentioned the potential of human induced pluripotent cells 
(iPS),38to substitute for ESC.39 This limited reference to iPS may have partly reflected 
the fact that international research on these cells was relatively new. Successful 
derivation of human iPS was only publicly reported in November 200740. 
 
Among ESCR supporters, those researchers who only worked with adult SCs 
indicated their interest in extending their work to embryonic cells because of their 
higher plasticity and potential to regenerate organs41, and only one scientist in this 
group referred to the future advantages of iPS as they do not involve embryo 
manipulation42. Some speakers explained that what was being used in research was a 
mass of cells and not the embryo itself 43. As this camp was trying to defend embryo 
research experimentation, they adopted an explicit strategy to focus on ESCR, instead 
of overtly and extensively referring to the potential benefits of iPS.  
 
The ‘morality-immorality’ of using research embryos was also set against the 
scientists´ moral responsibility by this group:  
 
Responsibility lies within the one  that recognises the therapeutic 
potential of embryo stem cells but blocks or does not prom ote its 
study. We cannot shirk our responsibility of working with embryonic 
SCs (Stevens Kastrup Rehen, a Catholic by background and an 
atheist embryonic SC scientist).44 
 
Technical and ethical aspects of ESCs divided Brazilian adult SCs´ researchers. 
However, an intense rivalry did not develop between the two scientific communities, 
as has been documented in other countries.45Narratives show that the field itself is 
still under definition locally, as a new and smaller epistemic community is being 
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Social and gender roles: motherhood, infertility and abortion  
Social and gender attributes, particularly with regard to infertility and motherhood 
permeated the debates, though for opposite reasons within each camp. The opposing 
bloc considered that: 
 
To be sure that an em bryo is viable or not, the only way to give it a 
chance is f or it to be im planted. The point is that when  several 
embryos are implanted not all are viable and develop till the end of 
gestation (Lenize Aparecida Martins Garcia, a practising Catholic 
and a professor of biology).47  
 
The defending bloc framed embryo research donation as a socio-ethical responsibility:  
 
What is ethically correct? To preserve frozen em bryos, even 
knowing that their probability of  generating a hum an being is 
practically zero, or dona te them for re search that could result in 
future treatments? (Mayana Zatz)48  
 
The embryo was construed as a direct contributor to the wellbeing of 
present and future generations  specially in one narrative (Deborah 
Diniz , a Catholic by background and an atheist, a leading 
bioethicist and anthropologist).49  
 
Positions upheld by both blocs converged in their disregard for the perspectives of 
research embryo donors. While one bloc defended the parents´ obligation to allow 
embryos to grow into babies, the other emphasises the parents’ social responsibility to 
support the development of future therapies based on embryo donation for research. 
The parents´ own perspectives on embryo research are absent from these narratives.  
 
Scientists also assumed, without offering evidence, that assisted fertilisation patients 
would agree to donate to ESCR. Estimates on sources of ESCR are based on the 
number of surplus embryos frozen within assisted fertilisation clinics, without 
knowing, whether and under what conditions and for what types of research, parents 
would consent to donation. Important motivations for embryo research donations, 
such as research aimed at the advancement of reproductive medicine, infertility 
treatment and embryo abnormality detection, were not mentioned during the local 
debates.50 
 
Two important aspects of embryo donation for research were excluded from the 
debate: a) the potential coercive or inducement effects on donations of the doctor-
patient or researcher-patient relationship; and b) the potential technical arbitrariness in 
embryo-grading, resulting from non-standardised classifications between fertility 
clinics.51, 52  
 
The opposing camp made a direct association between ESCR and abortion, a practice 
prohibited and criminalised in Brazil. Pre-existing sociocultural perspectives, 
transposed from abortion debates, permeated the arguments. References and analogies 
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were made to ‘pro-life’ arguments. ( The foetus was portrayed as feeling pain and 
influencing the mother´s psyche and hormones very early on; the mother as having a 
very early communication with the embryo/foetus.)53  
 
Hegemonic social attributes based on gender relations dominated the debate, 
including women’s social role as mothers and also as research donors.54 These 
attributes are interwoven into a referential framework developed almost exclusively 
by the scientific and medical establishment, defended as being superior, or the ‘only 
discourse with authority’;55 and given priority above other forms of knowledge, 
including that of the genitors of potential research embryos.  
 
Infertility, for both blocs, consequently becomes a valuable source of biological 
research materials and is repositioned within culturally hegemonic social 
perspectives.56 Infertile Brazilians, especially women, are directly or indirectly asked 
to work towards ‘the common good’. 
National competition in genetics and health biotechnology 
The rhetoric of the debate transmitted a certain hastiness to approve ESCR associated 
with Brazil´s international position in this field. ESCR supporters focused upon the 
global use of embryonic SCs to develop or test drugs and medicine, intellectual 
property rights protection and the Brazilian poor future lack of access to international 
SC-based drugs and therapies.57, 58 This group argued that the 2004 National Science, 
Technology and Innovation Plan59 had established biotechnology - including SCR - as 
one of its strategic priorities, thus providing the opportunity to develop advanced 
technology locally.60 
 
One of the main convergence zones between the blocs during the public debates was 
national pride in the country´s SCR with adult cells, particularly its global role: 
 
Brazil is the world champion in re lation to the diversity of clinical 
applications using adult SCs ... it is  one of the leading countries in 
the world that cu res its patients with th ese therapies (Rogerio 
Pazetti, a practising Catholic and a biologist and adult SC 
scientist).61  
 
Some of the pioneering local scientists in adult SCR formed part of the defence group 
(e.g. Antonio Campos de Carvalho, director of the National Network of Cellular 
Therapies and of the National Multicentre Random Trial on Heart Disease).62 
Strategically, the opponents emphasised the discourse on Brazil´s leading role in adult 
stem cells, to try to ban embryonic stem cell research.  
 
During the debates on Brazil´s global competition there were some key omissions. 
These included: potential public access to the eventual local cellular therapies; the 
prospective costs of these therapies; future relations with the biotechnology industry; 
potential ethnic and racial discrimination;63 and eventual commercial uses of these 
therapies for cosmetic ends.64 
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Stem cell research debates revisited 
The Brazilian debates show some relevant local trends and social positions in relation 
to at least the following three topics: forms of scientific, technical and moral 
construction of discourse and regulation; social views on civil society´s engagement; 
and perceptions on Brazil´s contributions to global genetics. These topics will be 
briefly addressed taking as points of comparison relevant public SCR debates in other 
contexts and the wider Brazilian health and/or development context. 
 
The Brazilian public debates on SCR are relatively recent compared with most 
European and other developed countries,65 and do not form part of a structured public 
revision of human reproduction and genetic institutions and regulation. Many 
countries pioneering ESCR concentrate on the difficulty in establishing adequate 
regulatory frontiers for research objects that defy traditional rules and codes of 
practice.66 This is also the case in Brazil, in relation to one central aspect of the public 
debates: the use of viable and unviable embryos for experimentation. 
  
The ‘embryo question’ plays a dominant role in defining the content of the different 
local debates. The interpretations made, based on sociocultural and religious 
backgrounds (root religion or regularly practised religion - as acquired through family 
background and/or education and not necessarily being practised), determine 
specificities within these positions. Pragmatic perspectives dominant among defenders 
of ESCR are supported by ontological positions that are not so clearly defined and, 
sometimes, juxtapose and articulate elements of different approaches to life within a 
single argument. Brazilian opponents of ESCR articulate their exploration of 
biological facts and of related ethical frameworks and ontological references more 
coherently within their own perspective, but less systematically.  
 
Only sporadic elements of an ontological paradigm shift from the human embryo to 
the stem cell as the initial unit of life, key to other societies’ debates, are found in the 
Brazilian context.67 Also, the definition of hierarchies and grades between types of 
human research embryos, for example, between viable and unviable frozen and fresh 
embryos, although addressed by ESCR advocates, does not become a central axis of 
debates.68  
 
However, Brazilian debates largely converge with narratives in other countries´ SCR 
public debates in their utilitarian approach, emphasising the potential service that in-
vitro embryos might offer to society or to specific patients. Even among ESCR 
opponents, where Catholicism plays a central role in perceptions and narratives, a 
certain utilitarian perspective also prevails. However, when the Catholic religion is 
acquired by background and not regularly practised - as reflected in some of the 
narratives among ESCR defenders - the utilitarian approach apparently becomes even 
stronger; and it is even more marked among atheists.  
 
Brazilian perspectives on scientific and technical progress tend to deal with scientific 
discourse as a form of ‘authoritative knowledge’, and narratives tend to reflect 
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structured and quite evenly distributed cultural beliefs on trust in scientific and 
technological paths. The discursive tactics and strategies used for the construction of 
new frontiers in this field, reveal the use of dichotomies such as, ‘science’ and ‘non-
science’ and ‘good’ or ‘bad’ science, which play quite a central role in the 
controversies, and are supported by abundant references to international practices. 
However, there is no significant initiative to build a coherent and institutionally 
referenced scientific, technical and ethical framework that could give rise to distinct 
new concepts and vocabulary – e.g. that of ‘pre-embryos’- which would be useful to 
establish some uniformity and eventually generate points of inflection in the public 
debates,69 as well as contributing substantially to the design of new regulations.  
 
Politicisation of public health and ethics is a common feature of Brazilian public 
debates on different health topics.70 In the case of ESCR, morality is used as a resort 
and polarised between: the embryo versus the suffering patients or their families, or 
the rights of the embryo versus the scientists’ responsibilities. The potential patients 
are represented as being desperate for cures, despite a lack of consultation with some 
key patient groups and organisations for people with disabilities. For example, the 
multiple demands posed by international patient organisations, or individuals, 
defending their condition of disability or sensorial deprivation and their rights to an 
intergenerational transmission of selective forms of disability have not been addressed 
by the public debates in Brazil.71 This topic could have been discussed at the Supreme 
Court hearing by having some speakers to counterbalance the dominant perspective in 
which people with disabilities were portrayed as desperate for new SCR therapies. 
 
Lobbies for and against ESCR try to engage the ‘publics’ through a ‘hype and hope’ 
strategy ( meaning the use of information and emotional tones that exaggerate the 
benefits and delivery-times of potential therapies and cures and thus ‘hype’ eventual 
users´ expectations and hopes),72 but in significantly different ways. The ESCR 
defenders´ lobby mainly targets patients and families, while the opposition lobby 
mainly targets anti-abortion and religious groups. Also, Brazilian ‘bottom up’ public 
engagement campaigns on SCR are different to those in other countries. They have 
been based upon short-term lobbying strategies and voluntary public advocacy, rather 
than upon a stable and solid participation process and institution-building for policy 
decision-making.73  
 
In general, Brazilian patient organisations are smaller than, for example, most US or 
European equivalents, and are less active and articulate in public debates.74 The SCR 
‘publics’ are drawn mainly from a: ‘deficit top-down model’75 and, even though the 
Brazilian Government develops public consultation of concerned stakeholders for 
specific SCR topics, it lacks an appropriate design for an inclusive public consultation 
strategy. The voices of specific social movements in the public arena76 have been 
reduced to a minimum in past SCR public debates, with some exceptions.77 The 
Brazilian ‘publics’ are involved in these debates in ways that show a transition and/or 
disparity between the exercise of civil rights within a representative democracy, and 
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Scientists’ narratives on Brazil´s global participation in genetics and biotechnology 
are constructed with reference to the country´s international competitiveness and are 
intended to promote the acceptance of scientific progress in SCR. Cellular therapies 
are measured in terms of their potential for disease treatment and for the country´s 
competitiveness. This field is seen as an opportunity for Brazil´s international 
expansion, so the country´s national success in adult SCR tends to be ‘hyped.’  
 
There was an important omission in the construction of the National Congress public 
debates, the potential commercialisation and distribution of the eventual embryo-
based cellular therapies, a central issue for an emerging economy that seeks both 
better public health therapies and greater leadership in the international arena. This 
topic was not significantly addressed within the SFT public hearing either by the 
justices or the speakers. Given the rate of local innovation and developments in the 
area,79 it is particularly relevant to focus on this aspect in the future, i.e. the potential 
participation of the biotechnology and pharmaceutical industries in the development 
of SCR-based therapies for the public health system.  
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